Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. More
A flavonoid derived from citrus fruit has shown tremendous promise for preventing weight gain and other signs of metabolic syndrome which can lead to Type 2 Diabetes and increased risk of cardiovascular disease. More
London Health Sciences Centre (LHSC) and Lawson Health Research Institute
(Lawson) are pleased to announce a Canadian first in the treatment of lung
cancer. On May 13, 2009 surgeon and clinical researcher Dr. Richard Malthaner and oncologist Dr. Edward More
Western virologist Yong Kang's research now at toxicology testing stage, with phase 1 human clinical trials to begin as early as three months from now. More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More
Thanks to the support of The W. Garfield Weston Foundation Dr. Peter Cadieux has an opportunity to improve the wellbeing of people in our community and beyond. More
All rights reserved. Terms and Conditions | Contact us
